Contraception and sickle cell disease.
D001695:Biology; D001769:Blood; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D019049:Developed Countries; D004194:Disease; D005060:Europe; D005193:Family Planning Services; D030342:Genetic Diseases, Inborn; D006262:Health; D007267:Injections; D007434:Intrauterine Devices; D017258:Medroxyprogesterone Acetate; D010827:Physiology; D011634:Public Health; D012449:Safety; D006113:United Kingdom
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D017258:Medroxyprogesterone Acetate
Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods; Depo-provera; Developed Countries; Diseases; Europe; Family Planning; Health; Hematological Effects; Hemic System; Hereditary Diseases--women; Injectables; Iud; Literature Review; Medroxyprogesterone Acetate; Northern Europe; Oral Contraceptives; Physiology; Public Health; Safety; United Kingdom